/Dexcom%20Inc%20logo%20on%20sign-by%20Michael%20Vi%20via%20Shutterstock.jpg)
Valued at $33 billion by market cap, DexCom, Inc. (DXCM) is a global leader in continuous glucose monitoring (CGM) technology. Headquartered in San Diego, California, the company specializes in innovative solutions that empower individuals with diabetes to better manage their health through real-time glucose tracking. The company is set to release its Q4 earnings on Thursday, Feb. 13.
Ahead of this event, analysts project the medical device company to report a profit of $0.51 per share, up 2% from $0.50 per share in the year-ago quarter. The company has consistently surpassed Wall Street's bottom-line estimates in the last four quarterly reports. In the most recent quarter, DexCom posted an EPS of $0.45, surpassing the consensus estimate by 4.7%.